JP Morgan Maintains Neutral on Ionis Pharmaceuticals, Raises Price Target to $58

JP Morgan maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Neutral and raises the price target from $57 to $58.

Benzinga · 11/13/2019 13:25

JP Morgan maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Neutral and raises the price target from $57 to $58.